Pacira BioSciences (PCRX) Stock Chart & Stock Price History $24.24 -0.21 (-0.86%) Closing price 06/13/2025 04:00 PM EasternExtended Trading$24.19 -0.05 (-0.21%) As of 06/13/2025 04:55 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock Pacira BioSciences Stock Price Performance The Pacira BioSciences (PCRX) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has decreased 13.83%, with a year-to-date return of 28.66%. In the past month, the stock has decreased 0.86%, reflecting recent market activity. As of the latest close, Pacira BioSciences traded at $24.24 with a market cap of $1.12 billion and volume of 490,353 shares. Five years ago, the stock traded at $42.56, representing a 43.05% decrease over that period. At the time, it had a market cap of $1.97 billion and a volume of 552,774 shares. Receive PCRX Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Pacira BioSciences and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance-4.64%1 Month Performance-0.86%3 Month Performance+5.99%Year-To-Date Performance+28.66%1 Year Performance-13.83%5 Year Performance-43.05% PCRX Stock Chart for Saturday, June, 14, 2025 PCRX Chart by TradingView Pacira BioSciences Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization06/13/2025$24.45$24.24-0.86%$24.75$24.10490,353 shs$1.12 billion06/12/2025$24.34$24.45+0.45%$24.59$23.501.03 million shs$1.13 billion06/11/2025$24.87$24.34-2.13%$25.16$24.11888,688 shs$1.13 billion06/10/2025$25.42$24.87-2.16%$25.66$24.76543,608 shs$1.15 billion06/09/2025$25.97$25.42-2.12%$26.30$25.36552,134 shs$1.18 billion06/06/2025$26.74$25.97-2.88%$27.18$25.95431,551 shs$1.20 billion06/05/2025$26.98$26.74-0.89%$27.15$26.24677,245 shs$1.24 billion06/04/2025$26.40$26.98+2.20%$27.42$26.02657,185 shs$1.25 billion06/03/2025$26.24$26.40+0.61%$26.55$25.95375,874 shs$1.22 billion06/02/2025$25.79$26.24+1.74%$26.43$25.37427,764 shs$1.21 billion Get the Latest News and Ratings for PCRX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Pacira BioSciences and its competitors with MarketBeat's FREE daily newsletter. 05/30/2025$25.93$25.79-0.54%$25.99$25.36595,420 shs$1.19 billion05/29/2025$25.56$25.93+1.45%$25.96$25.33574,241 shs$1.20 billion05/28/2025$25.82$25.56-1.01%$25.98$25.45626,596 shs$1.18 billion05/27/2025$25.75$25.82+0.27%$26.44$25.72615,215 shs$1.20 billion05/26/2025$25.75$25.75$26.24$25.45477,629 shs$1.19 billion05/23/2025$26.07$25.75-1.23%$26.24$25.45477,629 shs$1.19 billion05/22/2025$26.14$26.07-0.27%$26.43$25.90616,356 shs$1.21 billion05/21/2025$26.75$26.14-2.28%$26.91$26.08776,958 shs$1.21 billion05/20/2025$26.15$26.75+2.29%$26.83$26.02787,625 shs$1.24 billion05/19/2025$25.86$26.15+1.12%$26.41$25.751.12 million shs$1.21 billion05/16/2025$25.60$25.86+1.02%$26.57$25.451.15 million shs$1.20 billion05/15/2025$24.45$25.60+4.70%$25.64$24.19755,266 shs$1.19 billion05/14/2025$23.40$24.45+4.49%$24.90$23.421.08 million shs$1.13 billion05/13/2025$25.09$23.40-6.74%$25.21$23.231.46 million shs$1.08 billion Related Companies Perrigo Stock Chart Supernus Pharmaceuticals Stock Chart Nektar Therapeutics Stock Chart Omeros Stock Chart Assembly Biosciences Stock Chart Cumberland Pharmaceuticals Stock Chart Eli Lilly and Company Stock Chart Johnson & Johnson Stock Chart AbbVie Stock Chart Merck & Co., Inc. Stock Chart Receive PCRX Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Pacira BioSciences and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:PCRX) was last updated on 6/14/2025 by MarketBeat.com Staff From Our PartnersTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredAn AI run of epic proportions is only getting startedI just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredSilicon Valley Gold RushA new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredOil Hits $74 - $100 Next?Oil Jumps 8.5% on Middle East Crisis Trump at Oil Fields Oil surged 8.5% to $74/barrel after Israel's Ir...The Oxford Club | Sponsored[First Look] Get in before potential 10X AI announcementsGo for 10X gains from the next big AI announcement — starting as soon as 7 days from now Former floor trade...Masters in Trading | SponsoredIs Elon's empire crumbling?The Tesla Shock Nobody Sees Coming While headlines scream "Tesla is doomed"... Jeff Brown has uncovered ...Brownstone Research | SponsoredBig Changes Coming to Social Security?According to legendary investor Louis Navellier... This new Trump move could soon not only save Social Secu...InvestorPlace | SponsoredWe’ve Entered the Most Bullish Phase of the CycleIt happens like clockwork. Every four years, the crypto market enters a new phase — and for those who know how...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Pacira BioSciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Pacira BioSciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
